menu
    • menu
    [{"orgOrder":0,"company":"IDEA Pharma Ltd","sponsor":"Candel Therapeutics","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"U.S.A","productType":"Microorganism","year":"2025","type":"Partnership","leadProduct":"Aglatimagene Besadenovec","moa":"||DNA polymerase","graph1":"Oncology","graph2":"Phase III","graph3":"IDEA Pharma Ltd","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Intratumoral Injection","sponsorNew":"IDEA Pharma Ltd \/ IDEA Pharma Ltd","highestDevelopmentStatusID":"10","companyTruncated":"IDEA Pharma Ltd \/ IDEA Pharma Ltd"}]

    Find Clinical Drug Pipeline Developments & Deals by IDEA Pharma Ltd

    Menu

    IDEA Pharma Ltd

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            IDEA Pharma Ltd

                            United Kingdom arrow
                            EPSC
                            Not Confirmed

                            IDEA Pharma Ltd

                            United Kingdom arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Aglatimagene Besadenovec,Valacyclovir

                            Therapeutic Area : Oncology

                            Study Phase : Phase III

                            Recipient : Candel Therapeutics

                            Deal Size : Undisclosed

                            Deal Type : Partnership

                            DEALS_DEV arrow-down

                            Candel & IDEA Pharma Partner to Advance CAN-2409 Commercialization Efforts

                            Details : Under this partnership, IDEA will provide strategic commercial input throughout the development and commercialization process for Candel’s lead asset, CAN-2409 (aglatimagene besadenovec).

                            Product Name : Undisclosed

                            Product Type : Microorganism

                            Upfront Cash : Undisclosed

                            March 20, 2025

                            Lead Product(s) : Aglatimagene Besadenovec,Valacyclovir

                            Therapeutic Area : Oncology

                            Highest Development Status : Phase III

                            Recipient : Candel Therapeutics

                            Deal Size : Undisclosed

                            Deal Type : Partnership

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth